Fortress Biotech (FBIOP) Short Interest Ratio & Short Volume

Short interest is the volume of Fortress Biotech shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 10,800 shares of FBIOP short. Learn More on Fortress Biotech's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FBIOP shares currently have a short interest ratio of 1.0. Learn More on Fortress Biotech's short interest ratio.

Fortress Biotech saw a decrease in short interest in December. As of December 31st, there was short interest totaling 10,800 shares, a decrease of 59.4% from the previous total of 26,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Fortress Biotech: LAVA Therapeutics (0.32%), Pharvaris (0.96%), Procaps Group S.A. (0.14%), and

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

Short selling FBIOP is an investing strategy that aims to generate trading profit from Fortress Biotech as its price is falling. FBIOP shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Fortress Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FBIOP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBIOP, twice per month. The most recent reporting period available is December, 31 2024.